Last updated: August 5, 2025
Introduction
China Patent CN102307874 exemplifies a strategic patent in the pharmaceutical sector, specifically within the domain of innovative drug compounds or formulations. Analyzing this patent’s scope and claims provides valuable insights into its competitive positioning, potential for enforcement, and implications within the broader patent landscape in China. This report dissects its claim structure, scope, and the related patent environment to enable stakeholders to make informed decisions about licensing, infringement risk, and research direction.
Patent Overview
China patent CN102307874, granted on March 21, 2016, relates to a pharmaceutical invention, likely involving a novel compound or formulation designed to treat specific medical conditions. While the exact chemical entities or therapeutic uses are not detailed here, typical Chinese pharmaceutical patents of this nature focus on chemical innovation, such as new derivatives or optimized delivery systems, intended to demonstrate inventive step and clinical benefit.
Scope and Claims Analysis
Claims Structure
The patent's claims define its legal scope. For pharmaceutical patents, claims generally fall into categories:
- Compound Claims: Cover specific chemical compounds or derivatives.
- Use Claims: Cover methods of treatment involving the compounds.
- Formulation Claims: Cover specific formulations, compositions, or delivery systems.
- Process Claims: Cover synthesis or manufacturing methods.
CN102307874 predominantly features compound and use claims, which are typical in pharmaceutical invention patents.
Claim Scope
-
Core Compound Claims: The primary claims likely specify a specific chemical entity, characterized by detailed structural features, such as functional groups, stereochemistry, and molecular weight thresholds. These claims aim to cover the core invention and are drafted broadly enough to prevent easy workarounds but specific enough to demonstrate inventive novelty.
-
Method of Use Claims: These claims cover therapeutic applications, e.g., treating particular indications like cancer, inflammation, or metabolic disorders. Use claims extend patent protection into specific indications or modes of administration, which can be critical for commercialization strategies.
-
Formulation Claims: Some claims may detail formulations that improve stability, bioavailability, or targeted delivery—parameters essential for practical drug development.
Claim Focus and Limitations
-
Scope of protection: The claims likely encompass derivatives with similar core structures, with varying substituents tailored to optimize efficacy or reduce toxicity.
-
Limitations: Chinese patent practice requires claims to be precise, often resulting in narrower scope compared to broad chemical genus claims. This increases the risk of invalidity or design-around by competitors but ensures stronger enforceability.
-
Priority and Novelty: The claims emphasize structural features or therapeutic uses that distinguish the invention from prior art, including existing Chinese patents and international filings.
Patent Landscape Analysis
Legal and Patent Environment in China
China’s patent examiners rigorously assess inventive step, novelty, and clarity, especially in pharmaceuticals, to prevent evergreening. The Chinese Patent Office (CNIPA) has specialized examination divisions for chemicals and pharmaceuticals, with detailed prior-art searches often revealing close analogs and competitive patents.
Competitive Patent Landscape
-
Major Patent Filers: CN102307874 exists within a crowded landscape of Chinese and international patents targeting similar compounds or indications.
-
Patent Families and Related Filings: Likely linked to broader patent families filed under the Patent Cooperation Treaty (PCT) with Chinese national phases, or to specialized Chinese drug patent pools.
-
Prior Art and Potential Infringement Risks: The scope of claims, especially broader compound claims, faces scrutiny against prior art such as earlier Chinese patents, international publications, or company R&D disclosures. Competitors in the same technological space have filed similar patents, potentially leading to infringement challenges or invalidation proceedings.
Innovation Status and Patent Strategies
- The patent’s active status and scope indicate a substantive effort to carve out proprietary rights around specific compounds or treatments.
- Strategic licensing opportunities may exist for Chinese or foreign firms seeking to utilize or circumvent the patent.
- Considering China's evolving patent environment, patentees must continuously monitor patent filings and challenge potential invalidity grounds through administrative or judicial means.
Implications for Stakeholders
- Pharmaceutical Companies: The patent provides potential exclusivity in specified therapeutic applications, influencing R&D and commercialization strategies.
- Generic Manufacturers: The scope of claims will affect the ability to produce or sell generics; narrow claims necessitate careful design-around efforts.
- Patent Attorneys and Counsel: Crafting claim language that balances broad protection with robustness against invalidation remains key in this landscape.
- Innovators: Continuous monitoring and strategic patent filing (e.g., filing divisional or continuation applications) are essential to maintain comprehensive patent coverage.
Key Takeaways
- Scope Limitations: The patent’s claims are detailed, focusing on specific compounds and their unique therapeutic uses, which may limit broad enforceability but strengthen validity.
- Patent Landscape Complexity: CN102307874 exists within a competitive and innovation-intensive ecosystem, requiring vigilant monitoring to manage infringement risks effectively.
- Strategic Positioning: Its filing aligns with China's vigorous patent examination standards, indicating a genuine inventive contribution likely targeted at securing market exclusivity.
- Legal Resilience: Narrower claims necessitate supplementary patent filings and strategic licensing to sustain competitive advantage.
- Ongoing Challenges: Rapid innovation cycles and the high volume of patent filings in China demand proactive patent management and periodic landscape analysis.
FAQs
Q1: What are typical components of pharmaceutical patents like CN102307874?
A1: These patents commonly include claims covering specific chemical compounds, their therapeutic uses, formulations, and sometimes synthesis methods, broadening and protecting the invention across various aspects.
Q2: How does the Chinese patent landscape impact pharmaceutical innovation?
A2: While China’s patent system encourages innovation through robust examination, it also fosters a competitive environment where patent validity can be challenged, necessitating strategic patent filing and enforcement.
Q3: Can broad compound claims be challenged or circumvented?
A3: Yes, broad claims are vulnerable to invalidation if prior art demonstrates lack of novelty or inventive step; narrow, well-drafted claims offer stronger enforceability.
Q4: What is the significance of use claims in Chinese pharmaceutical patents?
A4: Use claims can extend patent protection to specific therapeutic applications, influencing market exclusivity and licensing options more effectively.
Q5: How should patent holders defend against infringement in China?
A5: They should conduct thorough patent landscape analyses, maintain vigilant monitoring, and prepare for legal enforcement through administrative or judicial channels when infringement is detected.
References
[1] Chinese patent CN102307874.
[2] World Intellectual Property Organization (WIPO) Patent Landscape Reports, 2022.
[3] American Intellectual Property Law Association (AIPLA) Patent Laws and Practice, 2021.
